{"id":253177,"date":"2020-04-25T06:45:17","date_gmt":"2020-04-25T10:45:17","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=253177"},"modified":"2020-04-25T06:45:17","modified_gmt":"2020-04-25T10:45:17","slug":"ph-coordinates-with-japan-for-avigan-clinical-trial","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2020\/04\/25\/ph-coordinates-with-japan-for-avigan-clinical-trial\/","title":{"rendered":"PH coordinates with Japan for Avigan clinical trial"},"content":{"rendered":"
\"\"<\/a>
Aside from this medicine, Vergeire said the Philippines is exploring other ways to manage Covid-19 cases. (PIA file photo)<\/figcaption><\/figure>\n

MANILA<\/strong>\u00a0\u2013 The Philippines is in the initial stages of coordination with the Japanese government for the planned clinical trials of Avigan for coronavirus disease 2019 (Covid-19) patients in the country.<\/p>\n

“Nagkaroon po tayo ng kasunduan sa<\/em>\u00a0government of Japan\u00a0kung saan mayroon po tayong pagkakasunduan, kung magiging<\/em>\u00a0clear\u00a0po ang ating<\/em>\u00a0arrangement,\u00a0ito pong isang gamot ay<\/em>\u00a0Avigan\u00a0pero nasa<\/em>\u00a0initial stages of coordination\u00a0pa lang tayo<\/em>\u00a0(We had an agreement with the government of Japan, once the arrangement has been clear, the medicine would be Avigan. At present we are in the initial stages of coordination),” DOH Undersecretary Maria Rosario Vergeire said Saturday during the Laging Handa briefing.<\/p>\n

Avigan, a Japanese anti-influenza drug otherwise known as Faviravir, has been touted as a promising treatment for Covid-19.<\/p>\n

Aside from this medicine, Vergeire said the Philippines is exploring other ways to manage Covid-19 cases.<\/p>\n

“Sa<\/em>\u00a0UP (PGH),\u00a0nag-umpisa na po sila ng kanilang<\/em>\u00a0convalescent plasma therapy\u00a0na<\/em>\u00a0clinical trial,\u00a0naumpisan na sa ibang pasyente at mayroon na silang nire-<\/em>report\u00a0na maganda pero hindi pa po ‘yan<\/em>\u00a0enough evidence\u00a0na kumpleto para masabi na ito talaga ay epektibo<\/em>\u00a0(At UP, they already started their convalescent plasma therapy on clinical trial, they’ve been reporting good results but that is not enough evidence to say this is really effective),” she said.<\/p>\n

The University of the Philippines-Philippine General Hospital (UP-PGH) is the only hospital in the country with approved protocol to conduct such procedure, said Vergeire.<\/p>\n

Meanwhile, some 21 Philippine hospitals enrolled for the World Health Organization’s Solidarity trial involving four off-label drugs reportedly effective in managing Covid-19 cases.<\/p>\n

READ: PH hospitals to join WHO solidarity trial<\/strong><\/a><\/p>\n

The hospitals include the PGH in Manila, The Medical City in Pasig, San Lazaro Hospital in Manila, Lung Center of the Philippines in Quezon City, Research Institute for Tropical Medicine in Muntinlupa, Baguio General Hospital in Benguet, East Avenue Medical Center in Quezon City, Makati Medical Center in Makati, St. Lukes Medical Center Global, St. Lukes Medical Center Quezon City, University of the East Ramon Magsaysay Medical Center in Quezon City, Cardinal Santos Medical Center in San Juan, Manila Doctors Hospital in Manila, Manila Medical Center in Manila, Chinese General Hospital in Manila, San Juan de Dios Medical Center in Pasay, Diliman Doctors Hospital in Quezon City, University of Santo Tomas Hospital in Manila, Vicente Sotto Medical Center in Cebu, Southern Philippines Medical Center in Davao, and World Citi Medical Center in Quezon City.<\/p>\n

As of April 24, the Philippines has a total of 7,192 confirmed Covid-19 cases, of whom 762 recovered while 477 died.<\/p>\n","protected":false},"excerpt":{"rendered":"

MANILA\u00a0\u2013 The Philippines is in the initial stages of coordination with the Japanese government for the planned clinical trials of …<\/p>\n","protected":false},"author":44,"featured_media":250316,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,95],"tags":[],"class_list":["post-253177","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","category-news-ph","mauthors-joyce-ann-l-rocamora","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/253177","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=253177"}],"version-history":[{"count":1,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/253177\/revisions"}],"predecessor-version":[{"id":253178,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/253177\/revisions\/253178"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/250316"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=253177"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=253177"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=253177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}